146 related articles for article (PubMed ID: 29425464)
1. Renin-angiotensin system inhibition ameliorates CCl
Saber S; Mahmoud AAA; Helal NS; El-Ahwany E; Abdelghany RH
Can J Physiol Pharmacol; 2018 Jun; 96(6):569-576. PubMed ID: 29425464
[TBL] [Abstract][Full Text] [Related]
2. Perindopril, fosinopril and losartan inhibited the progression of diethylnitrosamine-induced hepatocellular carcinoma in mice via the inactivation of nuclear transcription factor kappa-B.
Saber S; Mahmoud AAA; Goda R; Helal NS; El-Ahwany E; Abdelghany RH
Toxicol Lett; 2018 Oct; 295():32-40. PubMed ID: 29859236
[TBL] [Abstract][Full Text] [Related]
3. Effect of losartan, an angiotensin II antagonist, on hepatic fibrosis induced by CCl4 in rats.
Wei YH; Jun L; Qiang CJ
Dig Dis Sci; 2004 Oct; 49(10):1589-94. PubMed ID: 15573910
[TBL] [Abstract][Full Text] [Related]
4. Diethylcarbamazine attenuates the expression of pro-fibrogenic markers and hepatic stellate cells activation in carbon tetrachloride-induced liver fibrosis.
França MER; Rocha SWS; Oliveira WH; Santos LA; de Oliveira AGV; Barbosa KPS; Nunes AKS; Rodrigues GB; Lós DB; Peixoto CA
Inflammopharmacology; 2018 Apr; 26(2):599-609. PubMed ID: 28409388
[TBL] [Abstract][Full Text] [Related]
5. Magnesium chenoursodeoxycholic acid ameliorates carbon tetrachloride-induced liver fibrosis in rats.
Kang JW; Yoon SJ; Sung YK; Lee SM
Exp Biol Med (Maywood); 2012 Jan; 237(1):83-92. PubMed ID: 22185916
[TBL] [Abstract][Full Text] [Related]
6. Oligo-peptide I-C-F-6 inhibits hepatic stellate cell activation and ameliorates CCl
Sun H; Chen G; Wen B; Sun J; An H; Pang J; Xu W; Yang X; He S
J Pharmacol Sci; 2018 Mar; 136(3):133-141. PubMed ID: 29501581
[TBL] [Abstract][Full Text] [Related]
7. Lisinopril inhibits nuclear transcription factor kappa B and augments sensitivity to silymarin in experimental liver fibrosis.
Saber S; Goda R; El-Tanbouly GS; Ezzat D
Int Immunopharmacol; 2018 Nov; 64():340-349. PubMed ID: 30243070
[TBL] [Abstract][Full Text] [Related]
8. Anti-fibrogenic function of angiotensin II type 2 receptor in CCl4-induced liver fibrosis.
Nabeshima Y; Tazuma S; Kanno K; Hyogo H; Iwai M; Horiuchi M; Chayama K
Biochem Biophys Res Commun; 2006 Aug; 346(3):658-64. PubMed ID: 16774739
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic potential of morin against liver fibrosis in rats: modulation of oxidative stress, cytokine production and nuclear factor kappa B.
Heeba GH; Mahmoud ME
Environ Toxicol Pharmacol; 2014 Mar; 37(2):662-71. PubMed ID: 24583409
[TBL] [Abstract][Full Text] [Related]
10. Antifibrotic effect of meloxicam in rat liver: role of nuclear factor kappa B, proinflammatory cytokines, and oxidative stress.
Hassan MH; Ghobara MM
Naunyn Schmiedebergs Arch Pharmacol; 2016 Sep; 389(9):971-83. PubMed ID: 27245167
[TBL] [Abstract][Full Text] [Related]
11. Assessment of Hepatoprotective Effect of Chokeberry Juice in Rats Treated Chronically with Carbon Tetrachloride.
Piotrowska-Kempisty H; Nowicki M; Jodynis-Liebert J; Kurpik M; Ewertowska M; Adamska T; Oszmiański J; Kujawska M
Molecules; 2020 Mar; 25(6):. PubMed ID: 32168847
[TBL] [Abstract][Full Text] [Related]
12. Melatonin limits the expression of profibrogenic genes and ameliorates the progression of hepatic fibrosis in mice.
Crespo I; San-Miguel B; Fernández A; Ortiz de Urbina J; González-Gallego J; Tuñón MJ
Transl Res; 2015 Feb; 165(2):346-57. PubMed ID: 25445210
[TBL] [Abstract][Full Text] [Related]
13. Thalidomide in rat liver cirrhosis: blockade of tumor necrosis factor-alpha via inhibition of degradation of an inhibitor of nuclear factor-kappaB.
Paul SC; Lv P; Xiao YJ; An P; Liu SQ; Luo HS
Pathobiology; 2006; 73(2):82-92. PubMed ID: 16943688
[TBL] [Abstract][Full Text] [Related]
14. Angiotensin-I-converting enzyme inhibitors may be an alternative anti-angiogenic strategy in the treatment of liver fibrosis and hepatocellular carcinoma. Possible role of vascular endothelial growth factor.
Yoshiji H; Kuriyama S; Fukui H
Tumour Biol; 2002; 23(6):348-56. PubMed ID: 12677092
[TBL] [Abstract][Full Text] [Related]
15. Liuweiwuling tablets attenuate BDL-induced hepatic fibrosis via modulation of TGF-β/Smad and NF-κB signaling pathways.
Liu H; Dong F; Li G; Niu M; Zhang C; Han Y; He L; Yin P; Wang B; Sang X; Li R; Wang J; Bai Z; Xiao X
J Ethnopharmacol; 2018 Jan; 210():232-241. PubMed ID: 28864168
[TBL] [Abstract][Full Text] [Related]
16. Locostatin Alleviates Liver Fibrosis Induced by Carbon Tetrachloride in Mice.
Ma J; Qiu Y; Wang M; Zhang M; Zhao X; Jiang H
Dig Dis Sci; 2019 Sep; 64(9):2570-2580. PubMed ID: 30874989
[TBL] [Abstract][Full Text] [Related]
17. The comparative efficacy of renin-angiotensin system blockers in schistosomal hepatic fibrosis.
Parreira NA; Ramalho FS; Augusto MJ; Silva DM; Prado CM; Elias Júnior J; Rodrigues V; Ramalho LNZ
Exp Parasitol; 2018 Aug; 191():9-18. PubMed ID: 29890165
[TBL] [Abstract][Full Text] [Related]
18. Gypenosides Ameliorate Carbon Tetrachloride-Induced Liver Fibrosis by Inhibiting the Differentiation of Hepatic Progenitor Cells into Myofibroblasts.
Chen J; Li X; Hu Y; Liu W; Zhou Q; Zhang H; Mu Y; Liu P
Am J Chin Med; 2017; 45(5):1061-1074. PubMed ID: 28659031
[TBL] [Abstract][Full Text] [Related]
19. Protective effects of seed melon extract on CCl
Zhan YY; Wang JH; Tian X; Feng SX; Xue L; Tian LP
J Ethnopharmacol; 2016 Dec; 193():531-537. PubMed ID: 27717904
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of NK2 promotes liver fibrosis in carbon tetrachloride-induced chronic liver injury.
Hagiwara S; Otsuka T; Yamazaki Y; Kosone T; Sohara N; Ichikawa T; Sato K; Kakizaki S; Takagi H; Mori M
Liver Int; 2008 Jan; 28(1):126-31. PubMed ID: 17976157
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
